Prakt. lékáren. 2020; 16(3): 188-192

Probiotics and bacterial lysates as an alternative non-antibiotic strategy in supportive treatment of uncomplicated urinary tract infections

Hana Kotolová
Ústav humánní farmakologie a toxikologie, Farmaceutická fakulta, Veterinární a farmaceutická univerzita Brno

Urinary tract infections, along with respiratory tract infections, are the most frequent inflammatory diseases in man. Given the current situation of antibiotic resistance, non-antibiotic treatment strategies are also recommended in uncomplicated urinary tract infections. Non-antibiotic strategies can effectively be implemented by recommending appropriate daily routine measures supported by a well-chosen over-the-counter medicinal product, a healing tea blend, or a food supplement. Current knowledge of the microbiome as a modulator of a number of diseases has brought the anticipated positive use of probiotics and bacterial lysates as an interesting alternative in uncomplicated recurrent urinary tract infections.

Keywords: uncomplicated urinary tract infections, probiotics, bacterial lysates.

Published: October 8, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kotolová H. Probiotics and bacterial lysates as an alternative non-antibiotic strategy in supportive treatment of uncomplicated urinary tract infections. Praktické lékárenství. 2020;16(3):188-192.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Racionální léčba močových infekcí, včetně strategie dlouhodobé profylaxe u rekurencí. Farmakoterapeutické informace: FI * Číslo 1/2019 [online]. 2019; 1: 3-4. Dostupné z: http://www.sukl.cz/sukl/2019.
    2. Racionální léčba močových infekcí, včetně strategie dlouhodobé profylaxe u rekurencí. Farmakoterapeutické informace: FI * Číslo 2/2019 [online]. 2019; 2: 1-4. Dostupné z: http://www.sukl.cz/sukl/2019.
    3. Zámečník L, et al. Moderní farmakoterapie v urologii. Maxdorf Jessenius 2019. ISBN: 978-80-7345-609-2.
    4. Teplan V. Infekce ledvin a močových cest v dospělém a dětském věku. 1. vyd. Praha: Grada, 2004: 252 s. ISBN 80-247-0566-4.
    5. Matoušková M. Infekce močových cest, antimikrobiální léčba, podpůrná léčba. Remedia 2005; 15(4-5): 373-378.
    6. Žemličková H. Problémy antibiotické rezistence a zásady antibiotické léčby komunitních infekcí, situace v ČR. Med. praxi 2012; 9(8, 9): 329-332.
    7. Beerepoot M, Geerlings S. Non-Antibiotic Prophylaxis for Urinary Tract Infections. Pathogens. 2016; 5(2): 36. Go to original source... Go to PubMed...
    8. Bonkat G, et al. EAU Guidelines on Urological Infections, European Association of Urology 2018, https://uroweb.org/guideline/urological-infections/.
    9. Ryšávka P. Mikrobiom a vybraná onemocnění. Prakt. Lékáren 2019; 15(2): 91-94.
    10. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011; 52(10): 1212-1217. Go to original source... Go to PubMed...
    11. Bortlík M. Probiotika v gastroenterologii. Remedia 2009; 19(1): 47-51.
    12. Červený M. Probiotika a jejich klinické užití, abstrakta. Healthcom 2019: 42-43.
    13. Schwenger EM, et al. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database of Systematic Reviews 2015; 12. Art. No.: CD008772. 2015. Go to original source... Go to PubMed...
    14. Hoesl CE, et al. The Probiotic Approach: An Alternative Treatment Option in Urology. European Urology 2005, 47(3): 288-296. Go to original source... Go to PubMed...
    15. Bystroň J. Bakteriální imunomodulátory - současné použití v klinické praxi. Remedia 2010; 20(5): 298-304.
    16. Bauer HW, et al. Multicenter UTI Study Group. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol. 2005; 47(4): 542-548. Go to original source... Go to PubMed...
    17. MV-AISLP pro Windows, verze 4.2019 (SPC jednotlivých přípravků, u parafarmaceutik - oblast použití).
    18. Hanuš M, et al. Imunostimulace polybakteriálním lyzátem (Urivac®) v prevenci recidivujících infekcí dolních močových cest. Ces Urol 2015; 19(1): 33-43. Go to original source...
    19. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007; 335(7610): 80. doi:10.1136/bmj.39231.599815.55. Go to original source... Go to PubMed...
    20. Beneš J. Antibiotika. Grada Publishing 2018. ISBN 978-80-271-0636-3.
    21. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015; 60(Suppl 2): S129-S134. doi:10.1093/cid/civ085. Go to original source... Go to PubMed...
    22. Lukáš M. Prebiotika, probiotika a střevní mikroflóra. Interní Med. 2015; 17(1): 14-17.
    23. Lata J, Juránková J. Střevní mikroflóra, slizniční bariéra a probiotika u některých interních chorob. Med. praxi 2012; 9(3): 106-112.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.